October 19th, 2026CHEST: The Face of Lung Cancer Has Changed, but Screening, Care Have GapsExperts at CHEST 2026 urge pulmonologists to keep lung cancer in mind for younger patients who never smoked, to order screening and biomarker testing themselves, and to advocate for patients' access to care.Read more
October 19th, 2026FDA Grants Accelerated Approval to Dostarlimab for dMMR Rectal CancerFDA granted accelerated approval to dostarlimab-gxly for dMMR or MSI-H locally advanced rectal cancer based on interim phase 2 AZUR-1 results.Read more
October 19th, 2026FDA Approves Ryzumvi for Presbyopia, Expanding its LabelPhentolamine 0.75% (Ryzumvi) won FDA approval for presbyopia based on the phase 3 VEGA-2 and VEGA-3 trials.Read more
October 19th, 2026Most Bariatric Surgery Candidates Meet New Clinical Obesity CriteriaNearly 3 in 4 bariatric surgery candidates had clinical obesity, a phenotype that BMI alone did not distinguish from preclinical obesity.Read more
October 19th, 2026FDA Approves First At-Home Subcutaneous Thyroid Eye Disease TreatmentSatralizumab, a first-in-class IL-6 receptor inhibitor, was approved for adults with thyroid eye disease based on the phase 3 SatraGO program.Read more
October 19th, 2026Endometriosis Guidelines Differ on Biomarkers and Repeat SurgeryA review of 47 endometriosis guidelines found most came from high-income settings and diverged on biomarkers, repeat surgery, and fertility referral.Read more
October 19th, 2026AAO 2026: Closing the Screening Gap in Diabetic RetinopathyThe meeting covered several topics in eye care, including how artificial intelligence (AI) can play a part in eye care.Read more
October 19th, 2026Intensive BP Lowering Cuts CV Events Regardless of CKD StatusA meta-analysis of 27 trials found a 15% cardiovascular risk reduction per 10-mm Hg lower systolic BP, with no added risk of kidney failure.Read more